Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists find new clues underlying mood disorders

15.10.2004


Certain genes are expressed differently in people with depression

Researchers have found altered gene activity in people who suffer from major depression, a discovery that may one day help doctors better diagnose and treat the condition. The research, conducted by a consortium of four universities, appears this week in the online edition of the Proceedings of the National Academy of Sciences USA (PNAS). Scientists found that the fibroblast growth factor system, which is a family of proteins involved in the growth, development and maintenance of nerve cells, had an overall decrease in levels in patients who had major depressive disorder. Proteins are the products of gene expression.

"This study is the first to implicate this particular family of gene products in major depression," said Edward G. Jones, professor of psychiatry and director of the Center for Neuroscience at UC Davis and a principal investigator of the study. "The fibroblast growth factor system is now important to consider when looking for causes of mood disorders."



Growth factors bind to receptors on the surface of cells, setting in motion a variety of biological activities. The fibroblast growth factors are critical during brain development and also help maintain the central nervous system in adulthood.

The scientists applied microarray technology, a powerful new tool used to create gene expression profiles, to biological samples from specific areas of the brain at autopsy. Recently deceased people who had suffered from major depressive disorder or bipolar disorder were compared to controls who had no mood disorder. Those with major depressive disorder had different amounts of fibroblast growth factors than the controls. Those with bipolar disorder did not show these differences.

Interestingly, subjects with major depression who had been treated with selective serotonin reuptake inhibitors (SSRIs), a common medication for depression, showed smaller changes in the fibroblast growth factor system than those who had not been treated. "The fact that fibroblast growth factors were not as altered in individuals treated with SSRIs suggests that these drugs may act on this system and may be responsible for alleviating symptoms of depression," said Jones, who is an authority on brain anatomy and is recognized as a leading researcher of the central nervous system. "Knowing this may help guide future pharmaceutical development."

Information gleaned from specific genetic profiles, however, can help pinpoint what biological mechanisms are impaired so that more specific drugs with fewer side effects can be developed, according to Jones. "Targeted therapeutics made possible by these new technological approaches offer the dream of ’personalized medicine,’ in which knowing each person’s genetic make-up can help determine how he or she should be treated," said Prabhakara Choudary, adjunct professor of psychiatry in the UC Davis Center for Neuroscience, who is co-investigator of the study. "I think this study moves us one small step closer to that goal."

Choudary also said that the fibroblast growth factor system may one day be useful in developing an accurate tool for diagnosing major depression.

In addition to Jones and Choudary at UC Davis, the study’s authors include: Huda Akil, Simon Evans, Stanley J. Watson, Juan F. Lopez, Robert C. Thompson, J. D. Stead, C. R. Neal and F. Meng from the University of Michigan in Ann Arbor; J. Z. Li and R.M. Myers from Stanford University’s Human Genome Center in Palo Alto, Calif.; and M.P. Vawter, H. Tomita D. M. Walsh, and W. E. Bunney from UC Irvine in Irvine, Calif.

Carole Gan | EurekAlert!
Further information:
http://www.ucdmc.ucdavis.edu

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>